The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Open accessAbstract
Background: Neuropsychiatric symptoms are nearly universal in dementia, yet little is known about their longitudinal course in the community. Objective: To estimate point and 5‐year period prevalence of neuropsychiatric symptoms in an incident sample of 408 dementia participants from the Cache County Study. Methods: The Neuropsychiatric Inventory assessed symptoms at baseline and at 1.5 years, 3.0 years, 4.1 years, and 5.3 years. Point prevalence, period prevalence and mean symptom severity at each time point were estimated. Results: Point prevalence for delusions was 18% at baseline and 34–38% during the last three visits; hallucinations, 10% at baseline and 19–24% subsequently; agitation/aggression fluctuated between 13% and 24%; depression 29% at baseline and 41–47% subsequently; apathy increased from 20% at baseline to 51% at 5.3 years; elation never rose above 1%; anxiety 14% at baseline and 24–32% subsequently; disinhibition fluctuated between 2% and 15%; irritability between 17% and 27%; aberrant motor behavior gradually increased from 7% at baseline to 29% at 5.3 years. Point prevalence for any symptom was 56% at baseline and 76–87% subsequently. Five‐year period prevalence was greatest for depression (77%), apathy (71%), and anxiety (62%); lowest for elation (6%), and disinhibition (31%). Ninety‐seven percent experienced at least one symptom. Symptom severity was consistently highest for apathy. Conclusions: Participants were most likely to develop depression, apathy, or anxiety, and least likely to develop elation or disinhibition. Give converging evidence that syndromal definitions may more accurately capture neuropsychiatric co‐morbidity in dementia, future efforts to validate such syndromes are warranted. Copyright © 2007 John Wiley & Sons, Ltd.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Agitation is common, persistent, difficult to treat, costly, and associated with severe adverse consequences for patients and caregivers.
“Agitation is common, persistent, difficult to treat, costly, and associated with severe adverse consequences for patients and caregivers1–5.”
From Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial (2014) · cites this paper as [2]
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Flagged first, then by citations
Research works printed but not linked: 23
- 10.1159/000067972 · DOI
- 10.1002/gps.1316 · DOI · Paper page
- 10.1212/WNL.53.2.321 · DOI · Paper page
- 10.1159/000017113 · DOI
- 10.1017/S1041610201007517 · DOI
- 10.1002/(SICI)1099-1166(199711)12:11<1074::AID-GPS696>3.0.CO;2-B · DOI
- 10.1097/00019442-200002000-00004 · DOI
- 10.1111/j.1532-5415.1999.tb07245.x · DOI
- 10.1176/appi.ajp.157.5.708 · DOI · Paper page
- 10.1002/gps.448 · DOI · Paper page
- 10.1002/gps.440 · DOI
- 10.1002/gps.1203 · DOI
- Morris J, 1994, Clinical Dementia Rating Scale
- 10.1097/00019442-200203000-00003 · DOI
- Rabins PV, 1999, Practical Dementia Care
- 10.1016/j.eurpsy.2004.09.031 · DOI
- 10.1097/00019442-200506000-00005 · DOI
- 10.1176/ajp.147.8.1049 · DOI · Paper page
- 10.1176/appi.neuropsych.15.3.340 · DOI
- 10.1002/gps.1025 · DOI
- 10.1001/jama.293.18.2211-b · DOI
- 10.1017/S1041610205001523 · DOI
- 10.1176/ajp.152.9.1349 · DOI
Cited by
Sorted by citations
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247
Self-citationEffect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial
Porsteinsson, A. P., Drye, L. T., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., et al. (2014) · JAMA · doi:10.1001/jama.2014.93 · Cited by 572
Self-citationIsmail, Z., for the NPS Professional Interest Area of the International Society of to Advance Alzheimer’s Research and Treatment (NPS-PIA of ISTAART), Agüera-Ortiz, L., Brodaty, H., Cieslak, A., Cummings, J., Fischer, C. E., Gauthier, S., Geda, Y. E., Herrmann, N., et al. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-160979 · Cited by 530
Self-citationNonpharmacologic Management of Behavioral Symptoms in Dementia
Gitlin, L. N., Kales, H. C., & Lyketsos, C. G. (2012) · JAMA · doi:10.1001/jama.2012.36918 · Cited by 495
Self-citationNeuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
Lanctôt, K. L., Amatniek, J., Ancoli‐Israel, S., Arnold, S. E., Ballard, C., Cohen‐Mansfield, J., Ismail, Z., Lyketsos, C., Miller, D. S., Musiek, E., et al. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.07.001 · Cited by 395
Self-citationManagement of agitation and aggression associated with Alzheimer disease
Ballard, C. G., Gauthier, S., Cummings, J. L., Brodaty, H., Grossberg, G. T., Robert, P., & Lyketsos, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.39 · Cited by 404
Self-citationLiss, J. L., Seleri Assunção, S., Cummings, J., Atri, A., Geldmacher, D. S., Candela, S. F., Devanand, D. P., Fillit, H. M., Susman, J., Mintzer, J., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13244 · Cited by 312
Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?
Rosenberg, P. B., Nowrangi, M. A., & Lyketsos, C. G. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.05.005 · Cited by 302
Self-citationExecutive Functions in Alzheimer Disease: A Systematic Review
Guarino, A., Favieri, F., Boncompagni, I., Agostini, F., Cantone, M., & Casagrande, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00437 · Cited by 280
Sertraline for the treatment of depression in Alzheimer disease
Rosenberg, P. B., Martin, B. K., Frangakis, C., Mintzer, J. E., Weintraub, D., Porsteinsson, A. P., Schneider, L. S., Rabins, P. V., Munro, C. A., Meinert, C. L., et al. (2010) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181c796eb · Cited by 250
Self-citationCurrent treatment options for Alzheimer’s disease and Parkinson’s disease dementia
Y.Y. Szeto, J., & J.G. Lewis, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151208112754 · Cited by 198
Rosenberg, P. B., Lanctôt, K. L., Drye, L. T., Herrmann, N., Scherer, R. W., Bachman, D. L., Mintzer, J. E., & ADMET investigators (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08099 · Cited by 191
Psychosis in Alzheimer disease—mechanisms, genetics and therapeutic opportunities
Ismail, Z., Creese, B., Aarsland, D., Kales, H. C., Lyketsos, C. G., Sweet, R. A., & Ballard, C. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00597-3 · Cited by 189
Self-citationManagement of Neuropsychiatric Symptoms in People with Dementia
Ballard, C., & Corbett, A. (2010) · CNS Drugs · doi:10.2165/11319240-000000000-00000 · Cited by 147
Psychotropic drug prescriptions in western European nursing homes
Janus, S. I. M., van Manen, J. G., IJzerman, M. J., & Zuidema, S. U. (2016) · International Psychogeriatrics · doi:10.1017/s1041610216001150 · Cited by 110
Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study
Vik‐Mo, A. O., Giil, L. M., Ballard, C., & Aarsland, D. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4933 · Cited by 99
Neuropsychiatric Profiles in Dementia
Johnson, D. K., Watts, A. S., Chapin, B. A., Anderson, R., & Burns, J. M. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31820d89b6 · Cited by 82
Arthur, P. B., Gitlin, L. N., Kairalla, J. A., & Mann, W. C. (2018) · International Psychogeriatrics · doi:10.1017/s104161021700237x · Cited by 71
Suicide and chronic traumatic encephalopathy
Iverson, G. L. (2016) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.15070172 · Cited by 66
Goukasian, N., Hwang, K. S., Romero, T., Grotts, J., Do, T. M., Groh, J. R., Bateman, D. R., & Apostolova, L. G. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031947 · Cited by 64
Quality of Life in Community-Dwelling Older Persons with Apathy
Groeneweg-Koolhoven, I., de Waal, M. W. M., van der Weele, G. M., Gussekloo, J., & van der Mast, R. C. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.024 · Cited by 46
Validation of noninvasive body sensor network technology in the detection of agitation in dementia
Bankole, A., Anderson, M., Smith-Jackson, T., Knight, A., Oh, K., Brantley, J., Barth, A., & Lach, J. (2012) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317512452036 · Cited by 40
Massot Mesquida, M., Tristany Casas, M., Franzi Sisó, A., García Muñoz, I., Hernández Vian, Ó., & Torán Monserrat, P. (2019) · BMC Geriatrics · doi:10.1186/s12877-018-1015-9 · Cited by 38
Teixeira, A. L., Rocha, N. P., & Gatchel, J. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1777774 · Cited by 33
Ahmed, M., Malik, M., Teselink, J., Lanctôt, K. L., & Herrmann, N. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00668-7 · Cited by 29
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial
Rosenberg, P. B., Drye, L. T., Porsteinsson, A. P., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., et al. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215001106 · Cited by 28
Self-citationLornstad, M. T., Aarøen, M., Bergh, S., Benth, J. Š., & Helvik, A.-S. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1126-y · Cited by 24
Zhu, Y., Song, T., Zhang, Z., Deng, C., Alkhalaf, M., Li, W., Yin, M., Chang, H. C. (., & Yu, P. (2022) · Journal of Gerontological Nursing · doi:10.3928/00989134-20220309-01 · Cited by 18
Metadata
- Authors
- Steinberg, M., Shao, H., Zandi, P., Lyketsos, C. G., Welsh‐Bohmer, K. A., Norton, M. C., Breitner, J. C. S., Steffens, D. C., & Tschanz, J. T.
- Affiliations
- Johns Hopkins University (US)
- Utah State University (US)
- University of Washington (US)
- Duke University (US)
- Corresponding author
- Steinberg, Martin
- ORCID
- Venue
- International Journal of Geriatric Psychiatry
- Publisher
- Wiley
- Published
- 2007-07-03
- Volume
- 23
- Issue
- 2
- Pages
- 170-177
- ISSN
- 0885-6230 (ISSN-L)
- 1099-1166
- PMC
- PMC2932652
- OpenAlex
- W2139214514
- Cited by
- 780
- References
- 2
- Citations by year
- 2026: 33 · 2025: 56 · 2024: 53 · 2023: 40 · 2022: 68 · 2021: 59 · 2020: 64 · 2019: 49 · 2018: 51 · 2017: 42 · 2016: 44 · 2015: 42 · 2014: 40 · 2013: 39 · 2012: 38
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- International Journal of Geriatric Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons - USU (Utah State University) (submittedVersion)
- Funders
- National Institute on Aging (R01AG011380, R01AG021136)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- neuropsychiatric symptoms, dementia, prevalence, delusions, hallucinations, agitation, depression, apathy, anxiety, elation, disinhibition, irritability, aberrant motor behavior, symptom severity, longitudinal course
- MeSH terms
- Aged, Anxiety, Delusions, Dementia, Depression, Female, Hallucinations, Humans, Irritable Mood, Longitudinal Studies, Male, Mental Status Schedule, Psychomotor Agitation, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review